Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share-Based Compensation - Schedule of Number of Other Equity Instruments (Details)

v3.22.0.1
Share-Based Compensation - Schedule of Number of Other Equity Instruments (Details)
12 Months Ended
Dec. 31, 2021
CAD ($)
shares
Dec. 31, 2020
CAD ($)
shares
Dec. 31, 2019
CAD ($)
shares
Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Outstanding, beginning of the year (shares) 134,618 209,657 260,755
Granted during the year (shares) 0 154,923 270,098
Vested during the year (shares) (94,058) (229,962) (321,196)
Outstanding, end of the year (shares) 40,560 134,618 209,657
Weighted average fair value at measurement date, other equity instruments granted | $ $ 0 $ 2.41 $ 0.80
Performance share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Outstanding, beginning of the year (shares) 56,841 61,051 63,156
Vested during the year (shares) (56,841) (4,210) (2,105)
Outstanding, end of the year (shares) 0 56,841 61,051